Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.2.7 (
heparinase
)
1,270
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Heparan sulfate normally binds to
heparin cofactor II
and modulates the coagulation pathway by inhibiting thrombin. However, when human
heparin cofactor II
was incubated with heparan sulfate,
heparin cofactor II
became degraded. Other glycosaminoglycans were tested, including hyaluronic acid, chondroitin sulfates, dermatan sulfate, and heparin, but only dextran sulfate also degraded
heparin cofactor II
. Pretreatment of heparan sulfate with
heparinase
reduced its
heparin cofactor II
-degrading activity. Heparan sulfate and dextran sulfate diminished the thrombin inhibitory activity of
heparin cofactor II
. Other serpins, including antithrombin III and pigment epithelium-derived factor, were also degraded by heparan sulfate. This is the first evidence of acidic polysaccharides exhibiting protein-degrading activity without the aid of other proteins.
...
PMID:Heparin cofactor II is degraded by heparan sulfate and dextran sulfate. 2560 Aug 5
<< Previous
1
2